Request Demo
Last update 23 Jan 2025
TP53RK x Reactive oxygen species
Last update 23 Jan 2025
Basic Info
Related Targets |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTRI/2013/02/003355
An open labeled, comparative, step-up phase-2 clinical study to assess bioavailability and efficacy of sodium alpha-ketoglutarate infusion injection in patients with cyanide overload
CTRI/2013/01/003331
A phase-II open labeled, comparative, field study to assess efficacy of oral sodium alpha-ketoglutarate in treating cyanide poisoning
CTRI/2013/02/003356
An open labeled, comparative, step-up phase-II clinical study to assess deposition and efficacy of sodium alpha-ketoglutarate nebulization fluid (submicron-sized) in management of hydrogen cyanide, methyl isocyanate (MIC) toxicity and ammonia gas exposure
100 Clinical Results associated with TP53RK x Reactive oxygen species
Login to view more data
100 Translational Medicine associated with TP53RK x Reactive oxygen species
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free